Keith Pietropaolo Selected Research

IDX184

1/2013	IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C.
12/2012	Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith Pietropaolo Research Topics

Disease

4	Infections 01/2020 - 01/2012
3	Chronic Hepatitis C 01/2013 - 01/2012
2	Fibrosis (Cirrhosis) 01/2020 - 09/2019
2	Liver Diseases (Liver Disease) 01/2013 - 12/2012
1	Fanconi Syndrome (Syndrome, Fanconi) 12/2017
1	Proteinuria 12/2017
1	Thalassemia 12/2017
1	Virus Diseases (Viral Diseases) 12/2012
1	Viremia 12/2012

Drug/Important Bio-Agent (IBA)

4	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2012
2	IDX184IBA 01/2013 - 12/2012
2	Alanine Transaminase (SGPT)IBA 01/2013 - 12/2012
2	Ribavirin (Virazole)FDA LinkGeneric 01/2013 - 01/2012
1	AT-511IBA 09/2019
1	purineIBA 09/2019
1	ProTidesIBA 09/2019
1	SP-420IBA 12/2017
1	Chelating AgentsIBA 12/2017
1	CreatinineIBA 12/2017
1	IronIBA 12/2017
1	desferrithiocinIBA 12/2017
1	Transaminases (Aminotransferases)IBA 12/2012
1	RNA (Ribonucleic Acid)IBA 12/2012
1	NucleotidesIBA 12/2012
1	Reverse Transcriptase InhibitorsIBA 08/2012
1	NucleosidesIBA 08/2012
1	IDX 899IBA 08/2012
1	Viral RNAIBA 01/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2012
1	IDX320IBA 01/2012
1	InterferonsIBA 01/2012

Therapy/Procedure

1	Therapeutics 08/2012
1	Duration of Therapy 01/2012